Abstracts

Left hemi-liver hypertrophy after right portal vein ligation versus embolization: A comparative study

Background In two-stage hepatectomy (TSH) for bilobar liver metastases from colorectal cancer, future liver remnant (FLR) growth can be achieved using several techniques...

06/27/2022

Sex differences in chemotherapy-induced toxicities in gastric cancer patients

Background Female patients have a higher risk for chemotherapy toxicities due to sex differences related to pharmacokinetics and pharmacodinamics. In the era of evolving...

06/27/2022

Diffusion-weighted magnetic resonance imaging as an early predictive marker of chemoradiotherapy response in squamous cell carcinoma of the anus: An individual patient data meta-analysis

Background Patients with squamous cell carcinoma of the anus (SCCA) are at risk of locoregional recurrence after chemoradiotherapy (CRT). An early prognostic marker of t...

06/27/2022

Combination of gemcitabine plus cisplatin compared to non-gemcitabine and cisplatin regimens as neo-adjuvant treatment in liver transplant recipients with cholangiocarcinoma

Background The Cholangiocarcinoma treatment options are constantly being updated in view of existing evidence in order to establish practice guidelines and consensus sta...

M. Abdelrahim ;

A. Esmail ;

A. Saharia ;

J. Xu ;

G. Umoru ;

H. Al-Rawi ;

06/27/2022

Stereotactic body radiation therapy (SBRT) for lung metastases from colorectal cancer: A single-institution experience

Background Colorectal cancer (CRC) is the third most common cancer diagnosed worldwide (1). The lung is one of the most commonly involved sites of distant metastasis, wi...

06/27/2022

Feasibility of gemcitabine plus cisplatin as neo-adjuvant in cholangiocarcinoma patients prior to liver transplantation

Background The cholangiocarcinoma management is continually reviewed in the current evidence basis in order to develop practice guidelines and consensus statements. Howe...

06/27/2022

Gastric cancer in Albania: Epidemiological, clinical and pathological characteristics

Background Gastric cancer incidence and mortality varies between Mediterranean countries. As the Mediterranean diet is considered one of the healthiest diet, gastric can...

06/27/2022

Exploratory biomarker findings from regorafenib plus toripalimab in patients with refractory metastatic colorectal cancer (REGOTORI study)

Background REGOTORI study is a phase 1b/2 clinical trial for MSI-L/MSS/pMMR refractory metastatic colorectal cancer (mCRC). Our group previously reported that regorafeni...

Z. Lv ;

X. Zou ;

Q. Zhao ;

F. Wang ;

Y. Yao ;

Y. Jin ;

M. Wang ;

T. Hou ;

Y. Chen ;

M. He ;

M. Li ;

Y. Huang ;

Z. Wang ;

06/27/2022

Outcomes of neoadjuvant and/or adjuvant treatment vs surgical resection alone for patients with cholangiocarcinoma: An inverse probability of treatment weighting with predictive nomogram

Background Cholangiocarcinoma (CCA) is a rare and heterogeneous cancer, whose incidence and related mortality is increasing globally. Adjuvant chemotherapy (AT) is commo...

06/27/2022

Prognostic value of conversion from RAS-mutated to RAS wild-type during treatment of metastatic colorectal cancer using liquid biopsies – real-world data of two Portuguese institutions

Background Determination of RAS and BRAF mutational status is standard-of-care in the management of metastatic colorectal cancer (mCRC). Liquid biopsy (LB) is a powerful...

06/27/2022